Results 1 to 10 of about 10,413 (156)

Vemurafenib and Radiosensitization [PDF]

open access: yesJAMA Dermatology, 2013
The BRAF inhibitor, vemurafenib, was recently approved for the treatment of patients with BRAFV600 metastatic melanoma. Wider use of this drug and longer follow-up periods of treatment are resulting in the emergence of a growing number of reports detailing new adverse effects.
Lise, Boussemart   +8 more
openaire   +2 more sources

Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector. [PDF]

open access: yes, 2014
A tumor-selective non-lytic retroviral replicating vector (RRV), Toca 511, and an extended-release formulation of 5-fluorocytosine (5-FC), Toca FC, are currently being evaluated in clinical trials in patients with recurrent high-grade glioma (NCT01156584,
Gruber, Harry E   +11 more
core   +2 more sources

Radiosensitization and apoptosis [PDF]

open access: yesOncogene, 1998
The toxicity of radiation to living tissues was discovered soon after the discovery of radioactivity itself and this toxicity is the basis for cancer therapy with radiation. Although this mode of therapy is often effective, its success is far from assured.
R J, Muschel   +3 more
openaire   +2 more sources

Cell line-specific efficacy of thermoradiotherapy in human and canine cancer cells in vitro [PDF]

open access: yes, 2019
Objective Aims were to investigate sensitivity of various human and canine cancer cell lines to hyperthermia and the influence of particular treatment conditions, and to analyze the DNA-damage response and mode of cell death in cell line radiosensitized
Nytko, Katarzina J.   +4 more
core   +2 more sources

RRx-001, A novel dinitroazetidine radiosensitizer. [PDF]

open access: yes, 2016
The 'holy grail' in radiation oncology is to improve the outcome of radiation therapy (RT) with a radiosensitizer-a systemic chemical/biochemical agent that additively or synergistically sensitizes tumor cells to radiation in the absence of significant ...
Bednarski, Mark   +7 more
core   +1 more source

Gold nanoparticle and mean inactivation dose of human intestinal colon cancer HT-29 cells [PDF]

open access: yes, 2015
Background: Mean inactivation dose is a useful radiobiological parameter for the comparison of human cell survival curves. Objectives: Given the importance and accuracy of these parameters, in the present study, the radio sensitivity enhancement of colon
Abbasian, M.   +5 more
core   +1 more source

Radiosensitizing Nucleosides [PDF]

open access: yesJNCI Journal of the National Cancer Institute, 1996
Chemotherapeutic drugs that perturb nucleotide metabolism have the potential to produce substantial sensitization of tumor cells to radiation treatment. The process is called radiosensitization, and the agents that induce it are called radiosensitizers.
C J, McGinn, D S, Shewach, T S, Lawrence
openaire   +2 more sources

Ataxia-Telangiectasia Mutated and the Mre11-Rad50-NBS1 Complex:Promising Targets for Radiosensitization [PDF]

open access: yes, 2012
Radiotherapy plays a central part in cancer treatment, and use of radiosensitizing agents can greatly enhance this modality. Although studies have shown that several chemotherapeutic agents have the potential to increase the radiosensitivity of tumor ...
Fujiwara, Toshiyoshi   +2 more
core   +1 more source

Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize. [PDF]

open access: yes, 2016
Tumour resistance to radiotherapy remains a barrier to improving cancer patient outcomes. To overcome radioresistance, certain drugs have been found to sensitize cells to ionizing radiation (IR).
Adams, Stephen R   +10 more
core   +1 more source

GBM radiosensitizers: dead in the water…or just the beginning? [PDF]

open access: yes, 2017
The finding that most GBMs recur either near or within the primary site after radiotherapy has fueled great interest in the development of radiosensitizers to enhance local control.
Bindra, Ranjit S.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy